Efficacy and Safety of Olverembatinib in Adult BCR::ABL1‐positive ALL with T315I Mutation or Relapsed/refractory Disease
British Journal of Haematology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined